Grace Capital’s Core Laboratories CLB Stock Holding History

Grace Capital’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-1,700	Closed	-$117K	–	186
2019 Q1	$117K	Hold	1,700	–	–	0.05%	179
2018 Q4	$101K	Hold	1,700	–	–	0.05%	188
2018 Q3	$197K	Sell	1,700 -3,000	-64%	-$338K	0.08%	161
2018 Q2	$593K	Buy	+4,700	New	+$572K	0.23%	101

Other funds holding CLB

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Grace Capital's CLB Position: Q2 2019 in Review

Grace Capital sold out of Core Laboratories (CLB) in Q2 2019, closing a stake of 1,700 shares — an estimated $117K sold.

Grace Capital first reported a position in CLB in Q2 2018 and held it in 4 quarters. The position peaked at $593K in Q2 2018. 304 funds tracked by Wall St. Rank hold CLB as of Q2 2019.

Grace Capital reported no remaining Core Laboratories position as of Q2 2019 after selling out during the quarter.
Grace Capital sold 1,700 Core Laboratories shares in Q2 2019, an estimated $117K.
Grace Capital first reported a position in Core Laboratories in Q2 2018 and held it in 4 quarters.
Grace Capital's Core Laboratories position peaked at $593K in Q2 2018.
304 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2019.

Based on Grace Capital's 13F filing for Q2 2019, filed 14 Aug 2019.